tiprankstipranks
Cigna (CI)
NYSE:CI
US Market
Want to see CI full AI Analyst Report?

Cigna (CI) Earnings Dates, Call Summary & Reports

3,613 Followers

Earnings Data

Report Date
Jul 30, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
7.56
Last Year’s EPS
7.2
Same Quarter Last Year
Based on 17 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Apr 30, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: consolidated revenue and EPS growth, a raised full-year EPS outlook, robust specialty and Cigna Healthcare performance, and meaningful innovation (rebate-free pharmacy model and AI-enabled savings). Primary headwinds centered on near-term PBS earnings pressure (28% decline) due to renewals and transition investments, a material special-items charge ($322M after-tax), and portfolio exits/strategic reviews that reduce near-term scope. Management presented these challenges as deliberate and manageable trade-offs to sharpen focus and accelerate long-term value creation.
Company Guidance
Cigna raised full‑year 2026 adjusted EPS guidance to at least $30.35 after a strong Q1 that delivered total revenues of $68.5B and adjusted EPS of $7.79 (16% YoY); Q1 included after‑tax special charges of $322M ($1.22/sh). Evernorth Q1 revenues rose 9% to $58.4B with pretax adjusted earnings up 2% to $1.5B (Specialty & Care Services pretax adj. earnings +20% to $1.1B; Pharmacy Benefit Services pretax adj. earnings -28% to $394M, ≈$150M decline YoY) and Evernorth full‑year adjusted income from operations is expected to be at least $6.9B (Q2 pretax seasonality similar to historical patterns). Cigna Healthcare posted Q1 revenues of $11.5B and pretax adjusted earnings of $1.5B, with a Q1 medical care ratio of 79.8% and full‑year pretax adjusted earnings guidance of at least $4.525B (first half slightly above 60% of the full year; full‑year MCR guidance unchanged at 83.7%–84.7%; Q2 MCR expected slightly above the high end). Capital and cash metrics: Q1 operating cash flow was $1.1B, debt‑to‑capital was 42.3% (improved 70 bps vs. year‑end 2025) and the company expects most 2026 operating cash flow in H2 and a lower debt‑to‑capital by year‑end; longer‑term PBM transition targets include at least 50% of PBS members on the new rebate‑free Signature model by year‑end 2028.
Strong Consolidated Results and Raised Guidance
Total revenues of $68.5 billion and adjusted EPS of $7.79 in Q1 2026 (16% year-over-year EPS growth). Company raised full-year 2026 adjusted EPS outlook to at least $30.35.
Evernorth Revenue Growth
Evernorth revenues grew 9% year-over-year to $58.4 billion in Q1 2026 with pretax adjusted earnings of $1.5 billion (slightly ahead of expectations).
Specialty & Care Services Momentum
Specialty and Care Services pretax adjusted earnings increased 20% year-over-year to $1.1 billion, driven by strong volume growth, biosimilar and specialty generic adoption, and contribution from the Shields Health Solutions investment.
Cigna Healthcare Outperformance
Cigna Healthcare pretax adjusted earnings were $1.5 billion with revenues of $11.5 billion; earnings grew 18% year-over-year. First-quarter medical care ratio (MCR) was 79.8%, favorable to expectations.
Progress on Prior Authorization and Customer Experience
Removed hundreds of tests/procedures from prior authorization in the U.S., decreasing medical prior authorization volume by ~15%. Cigna Healthcare ranked #1 by J.D. Power in digital experience satisfaction for commercial members for the second consecutive year.
Innovation: Rebate-Free Pharmacy Model and AI
Announced the transformative rebate-free pharmacy service model ("Signature") projected to deliver brand drug prices ~30% lower with full transparency; PBS selling season shows strong early market interest. Company is leveraging data and AI across businesses (e.g., predictive high-cost claimant model driving ~$2,000 per engaged member per year in savings).
Operational Efficiency and Digital Adoption
Digital and AI-enabled improvements contributed to a 20% reduction in inbound calls for digitally eligible Cigna Healthcare U.S. employer customers and a 25% reduction in inbound calls for PBS members versus two years ago.
Capital and Balance Sheet Discipline
Operating cash flow of $1.1 billion in Q1, debt-to-capitalization ratio improved to 42.3% (70 bps improvement vs. year-end 2025) and expected to be lower by year-end 2026; company reiterated capital allocation balance including reinvestment, dividends and share repurchases.

Cigna (CI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CI Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 2026
2026 (Q2)
7.55 / -
7.2
Apr 30, 2026
2026 (Q1)
7.60 / 7.79
6.7415.58% (+1.05)
Feb 05, 2026
2025 (Q4)
7.88 / 8.08
6.6421.69% (+1.44)
Oct 30, 2025
2025 (Q3)
7.64 / 7.83
7.514.26% (+0.32)
Jul 31, 2025
2025 (Q2)
7.16 / 7.20
6.727.14% (+0.48)
May 02, 2025
2025 (Q1)
6.35 / 6.74
6.474.17% (+0.27)
Jan 30, 2025
2024 (Q4)
7.83 / 6.64
6.79-2.21% (-0.15)
Oct 31, 2024
2024 (Q3)
7.23 / 7.51
6.7710.93% (+0.74)
Aug 01, 2024
2024 (Q2)
6.43 / 6.72
6.139.62% (+0.59)
May 02, 2024
2024 (Q1)
6.22 / 6.47
5.4119.59% (+1.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CI Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 30, 2026
$292.32$290.58-0.60%
Feb 05, 2026
$270.22$282.97+4.72%
Oct 30, 2025
$295.82$244.37-17.39%
Jul 31, 2025
$293.09$263.10-10.23%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cigna (CI) report earnings?
Cigna (CI) is schdueled to report earning on Jul 30, 2026, Before Open (Confirmed).
    What is Cigna (CI) earnings time?
    Cigna (CI) earnings time is at Jul 30, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CI EPS forecast?
          CI EPS forecast for the fiscal quarter 2026 (Q2) is 7.56.

            Cigna (CI) Earnings News

            CI Earnings: Cigna Rises on Strong Q1 Performance
            Premium
            Market News
            CI Earnings: Cigna Rises on Strong Q1 Performance
            2y ago
            Cigna (NYSE:CI) Surges on Q4 Beat, Raises Dividend By 14%
            Premium
            Market News
            Cigna (NYSE:CI) Surges on Q4 Beat, Raises Dividend By 14%
            2y ago